BACKGROUND Dexmedetomidine provides excellent sedation with minimal cardiovascular instability or respiratory depression and this has been widely used to attenuate intubation surge. This drug may be a useful adjunct to facilitate smooth tracheal extubation. The aim of this study was to evaluate the ability of dexmedetomidine to attenuate the haemodynamic responses during extubation. METHODS 50 patients of ASA Grade I-II aged 20-50 years, were randomly allocated into two groups to receive either dexmedetomidine 0.75 μg/Kg in 100 ml normal saline (Group D) or 100 ml of normal saline (Group C) infusion over 15 minutes, initiated 15 mins., before anticipated end of surgery. Heart rate, systolic, diastolic and mean arterial pressures were assessed before, during and after extubation. Extubation quality was rated using 5-point scale. Sedation was rated using Ramsay Sedation Scale. Any adverse event was noted. Results were tabulated and statistically analysed using SPSS Software. RESULTS There was initially insignificant difference in mean (±SD) HR, SBP, DBP in both the groups. HR became significantly higher at and after 5 minutes of start of infusion till observation continued in Group C. SBP, DBP, MAP were significantly lower (p < 0.05) in group D than 10 min after starting of infusion and thereafter in all observation made up to 15 minutes postoperatively. Extubation quality score of the majority of patients was superior in group D than in group C. Sedation score of most patients was 3 in group D and 2 in group C. The incidence of adverse effects was statistically insignificant between the two groups (p valve>0.05). CONCLUSIONS Dexmedetomidine (0.75 mcg/Kg) infusion stabilizes haemodynamics and facilitates smooth extubation without causing undue sedation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.